Insulin Resistance

Insulin resistance is a condition in which the body's cells respond poorly to the hormone insulin, so the pancreas has to make more and more of it to keep blood sugar normal. It is not a disease you can usually feel, but it sits at the root of prediabetes, type 2 diabetes, and much of the metabolic dysfunction that drives heart disease — and, importantly, it is often improvable through everyday changes.

What is insulin resistance?

Insulin is a hormone made by the pancreas. After you eat, it acts like a key that tells your cells — especially in muscle, fat, and the liver — to take glucose (sugar) out of the bloodstream and either use it for energy or store it. In insulin resistance, those cells stop responding normally to that key. Glucose lingers in the blood, so the pancreas compensates by pumping out extra insulin.

For a while, this compensation works: blood sugar stays in the normal range, but only because insulin levels are quietly running high (a state called hyperinsulinemia). This is why insulin resistance can exist for years before a routine glucose test ever looks abnormal. Over time, if the insulin-producing beta cells can no longer keep up with demand, blood glucose begins to rise — first into the prediabetes range, then potentially into type 2 diabetes (NIH; StatPearls).

Insulin resistance is best understood not as an on/off switch but as a spectrum of metabolic strain. It overlaps heavily with metabolic syndrome — a cluster of risk factors including abdominal obesity, high blood pressure, high triglycerides, low HDL ("good") cholesterol, and elevated fasting glucose — and is a central feature of conditions such as type 2 diabetes, prediabetes, polycystic ovary syndrome (PCOS), and metabolic dysfunction-associated steatotic liver disease (MASLD, formerly NAFLD).

Insulin resistance is a physiological state rather than a single billable diagnosis. Related conditions carry their own ICD-10 codes — for example, R73.03 for prediabetes and E88.81 for metabolic syndrome — while the broader concept of impaired glucose regulation is captured under R73.09.

What causes insulin resistance, and who is at risk?

Insulin resistance arises from a combination of genetics and, more powerfully, modifiable lifestyle and body-composition factors. The mechanism most researchers emphasize is the accumulation of excess fat where it does not belong — particularly visceral fat packed around the abdominal organs and fat deposited inside the liver and muscle. This ectopic fat releases free fatty acids and inflammatory signals that interfere with insulin's normal action inside cells (StatPearls; NIH).

Major contributing factors and risk groups include:

• Excess weight, especially central (abdominal) fat. Waist size is often a better predictor of insulin resistance than overall weight.
• Physical inactivity. Muscle is the body's largest sink for glucose; sedentary muscle takes up far less of it.
• Diets high in refined carbohydrates, added sugars, and sugar-sweetened beverages, along with chronic calorie excess.
• Family history of type 2 diabetes and certain genetic predispositions.
• Older age, though insulin resistance is rising sharply in younger adults and adolescents.
• Ethnicity — risk is higher among people of South Asian, Hispanic, Black, Native American, and Pacific Islander descent.
• Polycystic ovary syndrome (PCOS), which is strongly linked to insulin resistance (ACOG).
• Poor or insufficient sleep, obstructive sleep apnea, and chronic stress, which raise cortisol and worsen glucose handling.
• Certain medications, including some corticosteroids, antipsychotics, and others.
• A history of gestational diabetes.

Some causes are not lifestyle-related at all. Pregnancy induces a normal, temporary rise in insulin resistance. Rarer causes include genetic syndromes, hormonal disorders such as Cushing's syndrome and acromegaly, and certain inherited lipodystrophies (StatPearls).

It is worth stressing that insulin resistance is not exclusive to people with obesity. So-called "lean" or metabolically unhealthy normal-weight individuals can have significant insulin resistance, typically reflecting where their fat is stored and their muscle and activity levels rather than the number on the scale.

What are the symptoms of insulin resistance?

For most people, the honest answer is that insulin resistance itself produces no clear symptoms. This is precisely what makes it dangerous — it can advance silently for years. It is usually inferred from blood tests, body measurements, and associated conditions rather than from how a person feels.

When physical signs do appear, they tend to reflect the metabolic strain or the high insulin levels rather than the resistance directly:

• Acanthosis nigricans — velvety, darkened patches of skin, most often in the neck folds, armpits, or groin. This is one of the more specific visible clues and is linked to high insulin levels (StatPearls; AAD).
• Skin tags (acrochordons), which frequently accompany acanthosis nigricans.
• Increasing waist size or difficulty losing abdominal weight.
• In people whose blood sugar has begun to rise toward diabetes: increased thirst, frequent urination, fatigue, or blurred vision — though these are signs of elevated glucose, not of insulin resistance per se.

Because symptoms are unreliable, clinicians focus on screening high-risk individuals rather than waiting for complaints. The presence of acanthosis nigricans, a large waist circumference, PCOS, or a strong family history should prompt evaluation even in someone who feels well.

How is insulin resistance diagnosed?

There is no single, universally used clinical test that a doctor orders specifically labeled "insulin resistance test." In routine practice, the condition is identified indirectly — through glucose-based testing, surrogate calculations, and assessment of associated risk factors. Research settings use a precise measure (the hyperinsulinemic-euglycemic clamp), but that is impractical for everyday care (StatPearls).

The practical workup typically includes:

Glucose-based tests (the formal basis for prediabetes/diabetes). Per the American Diabetes Association (ADA) Standards of Care in Diabetes (2026), prediabetes — a downstream marker that insulin resistance has begun to outpace compensation — is defined by any of the following (ADA):

• Fasting plasma glucose of 100–125 mg/dL (impaired fasting glucose); 126 mg/dL or higher on two occasions indicates diabetes.
• HbA1c of 5.7%–6.4%; 6.5% or higher indicates diabetes.
• 2-hour plasma glucose of 140–199 mg/dL during a 75-gram oral glucose tolerance test (impaired glucose tolerance); 200 mg/dL or higher indicates diabetes.

Fasting insulin and HOMA-IR. Because insulin rises before glucose does, some clinicians measure fasting insulin and calculate the HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) from fasting glucose and insulin. Higher values suggest greater resistance. However, there is no single, internationally standardized cutoff, and results vary by laboratory, assay, and population — so HOMA-IR is best treated as a supportive clue rather than a definitive diagnosis, and it is not part of formal ADA diagnostic criteria.

Metabolic syndrome assessment. A widely used and practical proxy is to screen for metabolic syndrome. Under the 2009 harmonized definition (a joint statement involving the AHA, NHLBI, IDF and others), it is diagnosed when three or more of the following five are present (AHA/NHLBI harmonized criteria):

1. Elevated waist circumference (population-specific thresholds; commonly ≥40 inches/102 cm in men and ≥35 inches/88 cm in women in the U.S.).
2. Triglycerides ≥150 mg/dL (or treatment for it).
3. HDL cholesterol <40 mg/dL in men or <50 mg/dL in women (or treatment for it).
4. Blood pressure ≥130/85 mm Hg (or treatment for it).
5. Fasting glucose ≥100 mg/dL (or treatment for it).

Supporting labs. Clinicians often also check a lipid panel, liver enzymes (to screen for associated fatty liver), and may consider triglyceride-to-HDL ratio as a rough surrogate of insulin resistance.

How is insulin resistance treated?

Treatment follows a clear hierarchy: lifestyle change is the foundation for everyone, and medication is added for higher-risk individuals or those progressing toward diabetes. The goal is to reduce the metabolic load on the system, lower insulin demand, and prevent or delay type 2 diabetes and cardiovascular disease.

Lifestyle first — the cornerstone

Lifestyle modification is the most powerful and best-evidenced intervention. In the landmark Diabetes Prevention Program (DPP), an intensive lifestyle program reduced progression from prediabetes to type 2 diabetes substantially — and was more effective overall than the medication arm (ADA; NIH). The core elements:

• Weight loss, if overweight. Even a modest loss of around 5–7% of body weight meaningfully improves insulin sensitivity and lowers diabetes risk (the DPP targeted ~7%).
• Regular physical activity — roughly 150 minutes per week of moderate activity, combining aerobic exercise with resistance/strength training. Muscle that contracts takes up glucose even without insulin, so activity improves sensitivity directly, sometimes within days.
• Dietary change. Emphasizing whole foods, fiber, and unsaturated fats while cutting added sugars, sugar-sweetened beverages, and refined carbohydrates. The Mediterranean dietary pattern is among the best-supported. Total calorie reduction (when weight loss is the goal) matters more than any single "magic" food.
• Improving sleep and managing stress, since both poor sleep and chronic stress worsen glucose control.
• Reducing prolonged sitting — breaking up sedentary time has independent benefit.

These steps also improve the conditions that travel with insulin resistance — blood pressure, cholesterol, and fatty liver.

Over-the-counter and supplements

Evidence here is mixed and should be discussed with a clinician; supplements are not a substitute for lifestyle change or prescribed therapy. Some agents studied in this space include inositol (notably myo-inositol, with the most data in PCOS-related insulin resistance), magnesium (mainly when intake is low), berberine, chromium, and soluble fiber. Quality of evidence varies widely and product purity is unregulated. None is FDA-approved to treat insulin resistance, and some can interact with medications — so professional guidance is important before starting any.

Prescription options

There is no drug approved with the sole indication "insulin resistance." Instead, medications are prescribed for prediabetes risk reduction or for the associated conditions, and several improve insulin sensitivity as a benefit. Real drug classes and agents used include:

• Biguanides — metformin. The best-studied and most commonly used medication for diabetes prevention in higher-risk individuals; it reduces hepatic glucose output and improves insulin sensitivity. The ADA notes metformin may be considered for prevention, with the strongest benefit seen in people with higher BMI, younger adults, and those with prior gestational diabetes (ADA).
• GLP-1 receptor agonists (such as semaglutide and liraglutide) and dual GIP/GLP-1 agonists (tirzepatide), which drive weight loss and improve glycemic control; some have been shown to reduce progression to diabetes in certain populations (ADA).
• Thiazolidinediones (TZDs) such as pioglitazone, which directly improve insulin sensitivity but carry side effects including weight gain and fluid retention.
• Treatment of associated conditions — for example, metformin and inositol for PCOS-related insulin resistance (ACOG), and standard therapy for high blood pressure and cholesterol to address overall cardiovascular risk.
• Metabolic (bariatric) surgery, for appropriate candidates with obesity, can produce large, durable improvements in insulin sensitivity.

Drug choice is individualized based on weight, glucose level, other conditions, and cardiovascular risk, and should be made with a clinician.

Can insulin resistance be prevented or managed long-term?

In large part, yes — because its main drivers are modifiable. The same habits that reverse early insulin resistance also prevent it and keep prediabetes from progressing to diabetes:

• Maintain a healthy weight, and lose weight gradually if needed; preventing weight regain is as important as the initial loss.
• Stay active most days — combine aerobic activity with strength training, and break up long periods of sitting.
• Eat a fiber-rich, minimally processed diet and minimize sugary drinks and ultra-processed foods.
• Prioritize sleep and address sleep apnea if present.
• Manage blood pressure and cholesterol, and don't smoke.
• Get screened regularly if you have risk factors, so changes can be caught and acted on early.

Long-term management is a partnership with periodic re-checking (such as repeat HbA1c or fasting glucose) and steady attention to the cluster of cardiometabolic factors. The encouraging reality is that insulin sensitivity is dynamic — it can improve substantially, sometimes within weeks of consistent activity and dietary change, and early insulin resistance is frequently reversible before permanent beta-cell decline sets in.

When should you see a doctor?

Talk to a clinician for evaluation if you have risk factors — a large waist, a family history of type 2 diabetes, PCOS, a history of gestational diabetes, high blood pressure or abnormal cholesterol, or signs like acanthosis nigricans (darkened velvety skin patches) — even if you feel well, so your glucose and metabolic risk can be checked.

Seek prompt medical care if you develop symptoms that may signal that blood sugar has risen significantly, including:

• Excessive thirst and frequent urination
• Unexplained weight loss
• Persistent fatigue or blurred vision
• Frequent infections or slow-healing wounds
• Numbness or tingling in the hands or feet

Symptoms such as confusion, very rapid breathing, fruity-smelling breath, severe abdominal pain, or vomiting require emergency care, as they can indicate dangerously high blood sugar.

What is the outlook (prognosis) for insulin resistance?

For most people the outlook is favorable, especially when insulin resistance is caught and addressed early. Because the condition is largely driven by modifiable factors, sustained lifestyle change can restore much of the body's insulin sensitivity and meaningfully lower the chance of ever developing type 2 diabetes.

The prognosis depends heavily on what happens next. Left unaddressed, insulin resistance tends to progress — from compensated high-insulin states, to prediabetes, to type 2 diabetes — and it raises the long-term risk of cardiovascular disease, fatty liver disease, and other complications. Acted on early, that trajectory can often be slowed, halted, or partially reversed.

The key message is one of agency: insulin resistance is among the most modifiable of the major metabolic risk states. Good care for it looks a great deal like good heart-health care, and the benefits extend well beyond blood sugar to blood pressure, cholesterol, weight, and overall longevity.

Frequently asked questions

Can insulin resistance be reversed? Often, yes — particularly in its earlier stages. Sustained weight loss of around 5–7% of body weight, regular exercise (especially strength training plus aerobic activity), a fiber-rich diet low in added sugar, and better sleep can substantially improve insulin sensitivity, sometimes within weeks. The longer insulin resistance has progressed toward diabetes, the harder it is to fully reverse, which is why acting early matters.

Is insulin resistance the same as diabetes? No. Insulin resistance is an underlying state in which cells respond poorly to insulin; the pancreas compensates by making more. Diabetes occurs later, when the pancreas can no longer keep blood sugar in the normal range. Insulin resistance can exist for years with completely normal glucose tests, and it is a major driver of prediabetes and type 2 diabetes rather than the same condition.

What blood test shows insulin resistance? There is no single definitive test in routine care. Doctors usually rely on glucose-based tests (fasting glucose, HbA1c, or an oral glucose tolerance test) to detect prediabetes, sometimes alongside a fasting insulin level or a calculated HOMA-IR, plus a lipid panel and waist measurement. HOMA-IR has no universal cutoff and varies by lab, so it is treated as a supportive clue rather than a formal diagnosis.

What foods should I avoid with insulin resistance? The strongest evidence points to cutting back on sugar-sweetened beverages, sweets, refined and highly processed carbohydrates (like white bread, pastries, and sugary cereals), and ultra-processed foods. Emphasizing vegetables, legumes, whole grains, fiber, lean proteins, and healthy fats — broadly a Mediterranean-style pattern — is well supported. Total calories matter when weight loss is a goal; no single food cures insulin resistance.

Does insulin resistance cause weight gain, or does weight gain cause insulin resistance? The relationship runs in both directions and forms a cycle. Excess fat, especially around the abdomen and inside the liver, promotes insulin resistance; in turn, high insulin levels can make fat storage easier and weight loss harder. Breaking the cycle usually starts with activity and dietary change, which improve insulin sensitivity even before much weight is lost.

*This page is for general education and is not medical advice. Talk to a qualified healthcare professional about diagnosis and treatment decisions specific to you.*